Loss of heterozygosity at chromosome 1p in human breast cancer: Association with high S-phase, reduced patient survival and deletions at other chromosome regions

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 731-736

  Ragnarsson, Gisli ^a   Sigurdsson, Asgeir ^a   Eiriksdottir, Gudny ^a   Barkardottir, Rosa B ^a   Jonasson, Jon G ^a   Ingvarsson, Sigurdur ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

breast cancer; chromosome 1p; clinico pathology; loss of heterozygosity; multiple deletions

Indexed keywords

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL; TUMOR SUPPRESSOR GENE;

EID: 0029817934     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Devilee P and Cornelisse CJ: Review. Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113-130, 1994.
2. Cavenee WK and White RL: The Genetic Basis of Cancer. Sci Am: 50-57, 1995.
3. Chen LC, Kurisu W, Ljung BM, Goldman ES, Moore D II and Smith HS: Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84: 506-510, 1992.
4. Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwartz GF and Croce CM: Deletion and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res 55: 1752-1757, 1995.
5. Loupart ML, Armour J, Walker R, Adams S, Brammer W and Varley J: Allelic imbalance on chromosome 1 in human breast cancer. I. Minisatellite and RFLP analysis. Genes Chromosom Cancer 12: 16-23, 1995.
6. Bieche I, Champème MH, Matifas F, Cropp CS, Callahan R and Lidereau R: Two distinct regions involved in 1p deletions in human primary breast cancer. Cancer Res 53: 1990-1994, 1993.
7. Bieche I, Champème MH and Lidereau R: A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res 54: 4274-4276, 1995.
8. Munn KE, Walker RA and Varley JM: Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10: 1653-1657, 1995.
9. Hoggard N, Brintnell B, Howell A, Weissenbach J and Varley J: Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis. Genes Chomosom Cancer 12: 24-31, 1995.
10. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelénat H, Thomas G and Delattre O: Two distinct deleted regions on short arm of chromosome 1 in neuroblastoma. Gene Chromosom Cancer 10: 275-281, 1994.
11. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S and Brodeur GM: A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92: 5520-5524, 1995.
12. Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R: Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Molec Genet 4: 535-539, 1995.
13. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM and Testa JR: Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q and 9p in human malignant mesothelioma. Cancer Res 53: 4349-4355, 1993.
14. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF: Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86: 4614-4618, 1989.
15. Gibas Z, Weil S, Chen S-T and McCue PA: Deletion on chromosome arm 1p in a Mercel cell carcinoma (MCC). Genes Chromosom Cancer 9: 216-220, 1994.
16. Stock C, Ambros IM, Lion T, Haas OA, Zoubek A, Gadner H and Ambros PF: Detection of numerical and stuctural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosom Cancer 11: 40-50, 1994.
17. Simon D, Knowles BB and Weith A: Abnormalities of cromosome I and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6: 765-770, 1991.
18. Bardi G, Pandis N, Fenger C, Kronborg O, Bomme L and Heim S: Deletion of 1p36 as primary chromosomal aberration in intestinal tumorigenesis. Cancer Res 53: 1895-1898, 1993.
19. Mathew CGP, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ and Ponder BAJ: Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328: 524-526, 1987.
20. Bello MG, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A and Rey JA: Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer 9: 296-298, 1994.
21. Eiriksdottir G, Bergthorsson JT, Sigurdsson H, Gudmundsson J, Skirnisdottir S, Egilsson V, Barkardottir RB and Ingvarsson S: Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: association with clinical variables. Int J Oncol 6: 369-375, 1995.
22. Bragadottir G, Eiriksdottir G, Sigurdson A, Barkardottir RB, Gudmundsson J, Jonasson JG and Ingvarsson S: Loss of heterozygosity at chromosome 6q correlates with tumor progression and patient survival. Int J Oncol 7: 871-876, 1995.
23. Eiriksdottir G, Sigurdsson A, Jonasson GJ, Agnarsson BA, Sigurdsson H, Gudmundsson J, Bergthorsson JT, Barkardottir RB, Egilsson V and Ingvarsson S: Loss of heterozygosity on chromosome 9 in human breast cancer: correlation with clinical variables and genetic changes at other chromosome regions. Int J Cancer 64: 378-382, 1995.
24. Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, Egilsson V and Ingvarsson S: Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors wiht genetic alterations. Br J Cancer 72: 696-701, 1995.
25. Skirnisdottir S, Eiriksdottir G, Baldursson T, Barkardottir RB, Egilsson V and Ingvarsson S: High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S-phase. Int J Cancer 64: 112-116, 1995.
26. Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
27. Maniatis T, Fritsch EF and Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, 1982.
28. Thomthwaite JT, Sugerbaker EV and Temple WJ: Preparation of tissues for DNA flow cytometric analysis. Cytometry 1: 229-237, 1980.
29. Hedley DW, Friedlander ML and Taylor IW: Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 6: 327-333, 1985.
30. Hiddeman W, Schuman J and Andrceff M: Convention of nomenclature for DNA cytometry. Cytometry 5: 445-446, 1984.
31. Baisch H, Gohde W and Linden WA: Analysis of PCP-data to determine the fraction of cells in various phases of cell cycle. Radiat Environ Biophys 12: 31-39, 1975.
32. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
33. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1960.
34. Cox DR: Regression models and life-tables. J R Stat Soc (B) 34: 187-220, 1972.
35. Marth JD, Disteche C, Pratcheva D, Ruddle F, Krebs EG and Perlmuer RM: Localization of a lymphocyte-specific protein kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas. Proc Natl Acad Sci USA 83: 7400-7404, 1986.
36. Umbricht CB, Griffin CA, Hawkins AL, Grzeschik KH, O'Connell P, Leach R, Green ED and Kelly TJ: High-resolution genomic mapping of the three human replication protein A genes (RPA1, RPA2 and RPA3). Genomics 20: 249-257, 1994.
37. Modi WS, Farrar WL and Howard OMZ: Confirmed assignment of a novel human tyrosine kinase gene (JAK1A) to 1p32.3->31.3 by nonisotopic in situ hybridization. Cytogenet Cell Genet 69: 232-234, 1995.
38. Duncan AMV, Anderson LL, Funk CD, Abramovitz M and Adam M: Chromosomal localization of the prostanoid receptor gene family. Genomics 25: 740-742, 1995.
39. Warman ML, McCarthy MT, Perälä M, Vuoro E, Knoll JHM, McDaniels CN, Mayne R, Beier D and Olsen BR: The genes encoding α2(IX) collagen (COL9A2) map to human chromosome 1p32.3-1p33 and mouse chromosome 4. Genomics 23: 158-162, 1994.
40. Devilee P, van Vliet M, van Sloun P, Kuipers-Dijkshoorn NJ, Hermans J, Pearsson PL and Cornelisse CJ: Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6: 1705-1711, 1991.
41. Sato T, Akiyama F, Sakamoto G, Kasumi F and Nakamura Y: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51: 5794-5799, 1991.
42. Anderson TI, Gaustad A, Farrants GW, Nesland JM, Tweit KM and Borresen AL: Genetic alterations of tumor suppressor gene regions 3p, 11p, 13q, 17p and 17q in human breast carcinoma. Genes Chromosom Cancer 4: 113-121, 1992.
43. Borg A, Zhang QZ, Alm P, Olsson H and Sellberg G: The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 3914-3917, 1992.
44. Takita KI, Sato T, Migyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R and Nakamura Y: Correlation of loss of alleles on the short arm of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52: 3914-3917, 1992.